Belite Bio Inc
Ownership
Ownership Structure
Who owns Belite Bio Inc (BLTE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.5% of the shares are freely tradable; institutional investors hold 23.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Darwin Global Management, Ltd. | 7.64 | 3,077,219 | +0.6 | 06/30/2026 |
| Paradigm Biocapital Advisors LP | 3.06 | 1,232,877 | +10.6 | 06/30/2026 |
| UBS Group AG | 1.91 | 768,359 | +496.8 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 1.78 | 715,332 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 1.23 | 494,564 | -13.2 | 06/30/2026 |
| Holocene Advisors, LP | 1.23 | 494,495 | +488.2 | 03/31/2026 |
| Eventide Asset Management, LLC | 0.97 | 390,829 | +9.3 | 06/30/2026 |
| Deerfield Management Co | 0.75 | 304,013 | +30.0 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 0.70 | 281,805 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 0.97 | 390,829 | +9.3 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Lin Yu-Hsin | Chief Executive Officer | 70,134 | 11,908,753 $ | Sep 8, 2026 | direct |
| Chuang Hao-Yuan | Chief Financial Officer | 26,038 | 4,421,252 $ | Sep 8, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 2,700 | 198.09 | 534,845 |
| Sep 8, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 8,752 | 197.36 | 1,727,275 |
| Sep 8, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 6,058 | 196.54 | 1,190,642 |
| Sep 8, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 6,090 | 195.62 | 1,191,325 |
| Sep 8, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 2,400 | 194.33 | 466,399 |
| Sep 8, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 2,562 | 198.05 | 507,392 |
| Sep 8, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 4,605 | 197.23 | 908,244 |
| Sep 8, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 4,475 | 196.47 | 879,200 |
| Sep 8, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 4,120 | 195.60 | 805,889 |
| Sep 8, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 2,200 | 194.28 | 427,414 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 8,111 | 193.13 | 1,566,439 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 4,209 | 192.54 | 810,412 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 11,080 | 191.15 | 2,117,909 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 600 | 190.39 | 114,232 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 8,955 | 189.34 | 1,695,552 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 3,045 | 188.26 | 573,253 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 6,200 | 187.25 | 1,160,964 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 7,800 | 186.32 | 1,453,323 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 4,593 | 185.34 | 851,286 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 6,252 | 184.52 | 1,153,647 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 4,955 | 183.30 | 908,228 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 3,413 | 182.50 | 622,869 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 2,587 | 181.24 | 468,877 |
| Sep 4, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 2,635 | 180.29 | 475,071 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 4,602 | 193.12 | 888,727 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,398 | 192.40 | 653,788 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 1,800 | 190.63 | 343,140 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 6,200 | 191.09 | 1,184,754 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 1,900 | 188.59 | 358,318 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,900 | 187.16 | 729,942 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 4,600 | 186.35 | 857,187 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,872 | 185.28 | 717,408 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,569 | 184.57 | 658,744 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,759 | 183.27 | 688,899 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 2,000 | 182.49 | 364,985 |
| Sep 4, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 1,633 | 180.16 | 294,201 |
| Aug 12, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 223 | 180.57 | 40,267 |
| Aug 12, 2026 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 144 | 180.00 | 25,920 |
| Aug 12, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 223 | 180.57 | 40,267 |
| Aug 12, 2026 | Lin Yu-Hsin | Chief Executive Officer | Sell | 142 | 180.00 | 25,560 |
| Apr 22, 2026 | Nathan L Mata | Insider | Sell | 1,000 | 170.38 | 170,380 |
| Apr 20, 2026 | Nathan L Mata | Insider | Sell | 1,000 | 163.59 | 163,590 |
| Apr 17, 2026 | Nathan L Mata | Insider | Sell | 1,000 | 161.63 | 161,630 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.